An Overview of Amyotrophic Lateral Sclerosis

JAMA Clinical Reviews by American Medical Association

May 11, 202617:34Health

Amyotrophic lateral sclerosis (ALS), which affects about 25 000 individuals in the US, causes progressive weakness but has varied presentations. Several FDA-approved medications are now available for ALS. Author John Rav...

Related Episodes

Continue listening to more episodes from JAMA Clinical Reviews.

Vaccines for Cancer Treatment

Sep 21, 2026 - 20:12

Cancer vaccines stimulate immune cells to recognize proteins or mutations found on or within cancer cells...

Idiopathic Normal Pressure Hydrocephalus: Diagnosis and Treatment

Sep 14, 2026 - 19:14

Idiopathic normal pressure hydrocephalus (iNPH) affects approximately 1% to 4% of adults aged 65 years an...

Rheumatoid Arthritis

Sep 10, 2026 - 23:15

Rheumatoid arthritis can affect any synovial joint and cause irreversible damage, but early diagnosis and...

An Overview of Postural Orthostatic Tachycardia Syndrome (POTS)

Aug 24, 2026 - 28:43

POTS is a chronic autonomic disorder characterized by excessive orthostatic tachycardia and multisystem s...

Medication Treatments for Alcohol Use Disorder

Aug 19, 2026 - 20:14

Naltrexone, acamprosate, disulfiram, and topiramate are effective but underused medications for treatment...

Liquid Biopsy Tests for Cancer

Aug 10, 2026 - 23:48

Circulating tumor DNA (ctDNA)(liquid biopsies) can help monitor cancer progression, detect residual cance...

Patient-Clinician Communication About Physical Activity

Aug 6, 2026 - 10:35

Physical activity is an effective component of care for people with chronic medical conditions. In this p...

Classic Hodgkin Lymphoma

Aug 3, 2026 - 20:59

Hodgkin lymphoma is a relatively rare disease, with approximately 82 409 incident cases reported globally...